Abstract
Calcineurin mediates repression of plasma membrane Ca2+-ATPase-4 (PMCA4) expression in neurons, whereas c-Myb is known to repress PMCA1 expression in vascular smooth muscle cells (VSMC). Here, we describe a novel mouse VSMC line (MOVAS) in which 45Ca efflux rates decreased 50%, fura 2-AM-based intracellular Ca2+ concentrations ([Ca2+]i) increased twofold, and real-time RT-PCR and Western blot revealed a approximately 40% decrease in PMCA4 expression levels from G0 to G1/S in the cell cycle, where PMCA4 constituted approximately 20% of total PMCA protein. Although calcineurin activity increased fivefold as MOVAS progressed from G0 to G1/S, inhibition of this increase with either BAPTA or retroviral transduction with peptide inhibitors of calcineurin (CAIN), or its downstream target nuclear factor of activated T cells (NFAT) (VIVIT), had no effect on the repression of PMCA4 mRNA expression at G1/S. By contrast, Ca2+-independent activity of the calmodulin-dependent protein kinase-II (CaMK-II) increased eightfold as MOVAS progressed from G0 to G1/S, and treatment with an inhibitor of CaMK-II (KN-93) or transduction of a c-Myb-neutralizing antibody significantly alleviated the G1/S-associated repression of PMCA4. These data show that G1/S-specific PMCA4 repression in proliferating VSMC is brought about by c-Myb and CaMK-II and that calcineurin may regulate cell cycle-associated [Ca2+]i through alternate targets.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies / pharmacology
-
Benzylamines / pharmacology
-
Calcineurin / metabolism*
-
Calcineurin Inhibitors
-
Calcium-Calmodulin-Dependent Protein Kinase Type 2
-
Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
-
Calcium-Calmodulin-Dependent Protein Kinases / metabolism
-
Calcium-Transporting ATPases / genetics
-
Calcium-Transporting ATPases / metabolism*
-
Carrier Proteins / genetics
-
Cation Transport Proteins
-
Cell Line
-
Cell Membrane / enzymology
-
Cell Size / physiology
-
Chelating Agents / pharmacology
-
Egtazic Acid / analogs & derivatives*
-
Egtazic Acid / pharmacology
-
Enzyme Inhibitors / pharmacology
-
G1 Phase / physiology
-
Gene Expression Regulation, Enzymologic / physiology
-
Mice
-
Mice, Inbred C57BL
-
Muscle, Smooth, Vascular / cytology*
-
Muscle, Smooth, Vascular / enzymology*
-
Oligopeptides / genetics
-
Phenotype
-
Plasma Membrane Calcium-Transporting ATPases
-
Proto-Oncogene Proteins c-myb / immunology
-
Proto-Oncogene Proteins c-myb / metabolism
-
S Phase / physiology
-
Sulfonamides / pharmacology
-
Transfection
Substances
-
Antibodies
-
Benzylamines
-
Calcineurin Inhibitors
-
Carrier Proteins
-
Cation Transport Proteins
-
Chelating Agents
-
Enzyme Inhibitors
-
Oligopeptides
-
Proto-Oncogene Proteins c-myb
-
Sulfonamides
-
VIVIT peptide
-
KN 93
-
Egtazic Acid
-
Calcium-Calmodulin-Dependent Protein Kinase Type 2
-
Calcium-Calmodulin-Dependent Protein Kinases
-
Calcineurin
-
Plasma Membrane Calcium-Transporting ATPases
-
Atp2b1 protein, mouse
-
Calcium-Transporting ATPases
-
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid